The 5 Repetitions Sit-to-stand Test, Carried Out Remotely Via Videoconference, in Patients With COPD: Is There a Learning Effect?

NCT05852821 | Completed

• 1 other identifier: e-EVAL
• Study Type: interventional
• Target: 40
• Locations: 1 country
• Sites: 1

Brief Summary

The purpose of this clinical study is to determine if a learning effect exists when the 5STS is assessed remotely via videoconference in patients with COPD.

Conditions

Chronic Respiratory Disease

Outcome Measures

Primary Outcomes (1)

• the variation in time of 5STS between first assay and fifth assay during the first visit (V1).

  1 day

Secondary Outcomes (8)

• the variation in time of 5STS between each trial at the first visit (V1).

  1 day

• the variation in time of 5STS between the first visit (V1) and the second visit (V2).

  2 days

• the variation in time of 5STS between the second visit (V2) and the third visit (V3).

  1 month

• The reproducibility of the remote test

  1 month

• The number of tests not carried out

  through study completion, an average of 1 year

Study Arms (1)

remote 5STS through videoconference

EXPERIMENTAL

Other: 5STS remote assessment via videoconference

Interventions

5STS remote assessment via videoconference OTHER

Patients will be asked to perform several times the 5STS test, from their home through videoconference, on 3 occasions (day 1, 24h later and 1month later).

remote 5STS through videoconference

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Patients with a diagnosis of Chronic Obstructive Pulmonary Disease (COPD)
• Obtaining oral informed consent after a minimum reflection period of 24 hours
• Patient with internet access at home and a tool allowing the realization of a videoconference (smartphone or computer)

You may not qualify if:

• Patients who had a recent exacerbation (less than 4 weeks)
• Patients physically unable to get up from a chair and sit down without help
• Patients with significant and unstable cardiovascular disease
• Any acute or chronic pathology (orthopedic, neurological, psychiatric or causing a major cognitive disorder) limiting the performance of a functional test
• Inability or difficulty using digital tools
• Adults protected by law or patient under guardianship or curatorship
• Subjects deprived of liberty by a judicial or administrative decision
• Current or planned pregnancy during the study period
• Pregnant or breastfeeding women
• Patients not affiliated to a French social security scheme or not benefiting from such a scheme

Sponsors & Collaborators

• Korian: lead

Study Sites (1)

Clinique du Souffle la Vallonie

Lodève, 34700, France

Location

Study Officials

• Nelly HERAUD

  Director of research

  STUDY DIRECTOR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: NA
• Masking: NONE
• Purpose: SUPPORTIVE CARE
• Intervention Model: SINGLE GROUP
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: April 27, 2023
• First Posted: May 10, 2023
• Study Start: April 18, 2023
• Primary Completion: January 4, 2024
• Study Completion: January 4, 2024
• Last Updated: January 9, 2024

Record last verified: 2024-01

Data Sharing

• IPD Sharing: Will not share

Locations

FR (1)